HER2-negative相关论文
Anlotinib has good efficacy and low toxicity: a phase Ⅱ study of anlotinib in pre-treated HER-2 nega
Objective:Anlotinib is a novel tyrosine kinase inhibitor blocking angiogenesis.This study was performed to assess the ef......
Multicenter phaseⅡstudy of apatinib single or combination therapy in HER2-negative breast cancer inv
Objective:Breast cancer(BC)with chest wall metastasis(CWM)usually shows rich neovascularization.This trial explored the ......
目的观察老年HER2阴性晚期乳腺癌患者应用氟维司群联合瑞博西林的治疗效果。方法选取在武汉市中心医院新洲院区2017年6月-2019年6......
